Trevena Announces TRV027 Selected for Study in Global REMAP-CAP Trial in COVID-19 Patients
21 avr. 2021 07h00 HE
|
Trevena Inc.
-- REMAP-CAP is led by experts in pandemic response and builds upon a worldwide clinical trial network evaluating treatments for COVID-19 Interim review of Imperial College London TRV027 study data...